Unicentric hyaline vascular Castleman’s disease presenting as an intraparenchymal parotid mass: a rare case report

Sridhar R. Dandala; Vinod K. Gonuru; Manoranjani Dola

doi:10.18203/2320-6012.ijrms20252043

Authors

Sridhar R. Dandala Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
Vinod K. Gonuru Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
Manoranjani Dola Department of Otorhinolaryngology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20252043

Keywords:

Castleman’s disease, Benign lymphoproliferative disorder, Parotid gland

Abstract

Castleman’s disease (CD) is a rare, benign lymphoproliferative disorder of unknown etiology that can affect any lymph node group, with the mediastinum being the most common site. Salivary gland involvement is exceptionally rare. We present a case of a 30-year-old female with a slowly progressive, painless left-sided parotid swelling persisting for four months. Clinical examination, ultrasonography and fine-needle aspiration cytology (FNAC) initially suggested an intraparotid lymph node enlargement. The lesion was excised and histopathological examination confirmed hyaline vascular CD. Given its rarity and lack of specific clinical or radiological features, CD should be considered in the differential diagnosis of persistent parotid gland swellings. Surgical excision remains the mainstay of treatment for unicentric Castleman’s disease (UCD) with an excellent prognosis.

Metrics

Metrics Loading ...

References

Castleman B, Towne VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; Case No. 40351. N Engl J Med. 1954;251(10):396-400. DOI: https://doi.org/10.1056/NEJM195409022511008

Batra A, Goyal M. Castleman’s disease presenting as parotid mass: a case report. Int J Otorhinolaryngol Head Neck. 2019;5(2):504-6. DOI: https://doi.org/10.18203/issn.2454-5929.ijohns20190786

Gürbüzler L, Ceylan A, Yilmaz M, Vural C. Castleman's disease of the parotid gland: a case report. Kaohsiung J Med Sci. 2010;26(8):444-7. DOI: https://doi.org/10.1016/S1607-551X(10)70071-1

Iyer S, Bhatti MI, Halliday M. Castleman's disease-A case report. Int J Surg Case Rep. 2010;1(3):25-6. DOI: https://doi.org/10.1016/j.ijscr.2010.06.005

Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia. Cancer. 1972;29(3):670-83. DOI: https://doi.org/10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#

Samadi, Daniel S, Hockstein NG, Tom LWC. Pediatric intraparotid Castleman's disease. Ann Otol Rhinol Laryngol. 2003;112(9):813-6. DOI: https://doi.org/10.1177/000348940311200912

Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J, et al. Interleukin-6 gene expression in Castleman's disease. Blood. 1991;78(11):2923-30. DOI: https://doi.org/10.1182/blood.V78.11.2923.bloodjournal78112923

Haap M, Wiefels J, Horger M, Hoyer A, Müssig K. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides. Blood Rev. 2018;32(3):225-34. DOI: https://doi.org/10.1016/j.blre.2017.11.005

Williams DS. Castleman's disease. J Insur Med. 2013;43(4):256-8.

Reece B, Ord R, Papadimitriou J. Rare presentation of unicentric Castleman's disease in the parotid gland. J Oral Maxillofac Surg. 2012;70(9):2114-7. DOI: https://doi.org/10.1016/j.joms.2011.09.042

Bucher P, Chassot G, Zufferey G, Ris F, Huber O, Morel P. Surgical management of abdominal and retroperitoneal Castleman's disease. World J Surg Oncol. 2005;3:33. DOI: https://doi.org/10.1186/1477-7819-3-33